Statements (60)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Person
|
| gptkbp:bfsLayer |
3
|
| gptkbp:bfsParent |
gptkb:Asklepios_Bio_Pharmaceutical
|
| gptkbp:active_years |
2000-present
|
| gptkbp:advocates_for |
patient access to therapies
|
| gptkbp:affiliation |
gptkb:Alnylam_Pharmaceuticals
|
| gptkbp:alma_mater |
gptkb:Harvard_University
|
| gptkbp:awards |
biotechnology innovation award
|
| gptkbp:birth_place |
gptkb:United_States
|
| gptkbp:children |
not publicly disclosed
|
| gptkbp:collaborations |
academic institutions
with universities |
| gptkbp:conference |
international biotech summits
|
| gptkbp:contribution |
biomedical research
through innovation advancements in RNA therapeutics to RNA biology |
| gptkbp:education |
Ph. D. in biology
|
| gptkbp:field |
gptkb:Company
|
| gptkbp:future_plans |
expanding RNA technology
|
| gptkbp:has_role |
for aspiring scientists
|
| https://www.w3.org/2000/01/rdf-schema#label |
Dr. John M. Maraganore
|
| gptkbp:impact |
healthcare solutions
global health |
| gptkbp:inception |
Alnylam Pharmaceuticals founded in 2002
|
| gptkbp:influence |
drug discovery
biotech policy |
| gptkbp:influences |
genetic medicine
|
| gptkbp:inspiration |
in the field of RNA therapeutics
|
| gptkbp:is_committed_to |
patient-centered research
|
| gptkbp:is_involved_in |
clinical trials
drug development |
| gptkbp:key_people |
founder of Alnylam Pharmaceuticals
|
| gptkbp:known_for |
leadership in biotechnology
|
| gptkbp:leadership |
clinical research
collaborative empowerment of teams in biotech sector |
| gptkbp:membership |
various biotech organizations
|
| gptkbp:mentor |
young scientists
|
| gptkbp:nationality |
gptkb:Native_American_tribe
|
| gptkbp:network |
biotech industry leaders
|
| gptkbp:notable_work |
RNA interference technology
|
| gptkbp:occupation |
biotech executive
|
| gptkbp:partnerships |
pharmaceutical companies
|
| gptkbp:philanthropy |
support for scientific research
|
| gptkbp:philosophy |
innovation in medicine
|
| gptkbp:public_speaking |
biotechnology conferences
|
| gptkbp:publishes |
numerous scientific papers
|
| gptkbp:recognizes |
industry awards
|
| gptkbp:research_interest |
therapeutics
|
| gptkbp:residence |
gptkb:Cambridge,_Massachusetts
|
| gptkbp:role |
biotech innovation
various biotech firms |
| gptkbp:spouse |
not publicly disclosed
|
| gptkbp:strategic_importance |
advancing genetic medicine
on RNA therapeutics. |
| gptkbp:title |
gptkb:CEO
|
| gptkbp:vision |
future of medicine
transforming patient care |